Search
Emergent BioSolutions Inc
EBSAdd to Watchlist
8.130USD
+0.190+2.39%
Close 05/18, 16:00（ET）Quotes delayed by 15 min
421.13MMarket Cap
LossP/E TTM
More Details of Emergent BioSolutions Inc Company
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Emergent BioSolutions Inc Info
Ticker SymbolEBS
Company nameEmergent BioSolutions Inc
IPO dateNov 15, 2006
CEOPapa (Joseph C)
Number of employees900
Security typeOrdinary Share
Fiscal year-endNov 15
Address300 Professional Dr
CityGAITHERSBURG
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code20879
Phone12406313200
Websitehttps://emergentbiosolutions.com/
Ticker SymbolEBS
IPO dateNov 15, 2006
CEOPapa (Joseph C)
Company Executives of Emergent BioSolutions Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
114.67K
+22.10%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
89.36K
+28.36%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
79.44K
+31.90%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
59.03K
+16.71%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
By RegionUSD
Name
Revenue
Proportion
Non-U.S Government
403.20M
54.27%
U.S.Government
36.70M
4.94%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
Other
72.72%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
Other
72.72%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.35%
Investment Advisor/Hedge Fund
31.07%
Hedge Fund
8.77%
Research Firm
3.93%
Individual Investor
3.86%
Pension Fund
1.01%
Bank and Trust
0.36%
Family Office
0.06%
Insurance Company
0.02%
Other
13.55%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
412
42.30M
81.98%
-3.37M
2025Q4
378
39.86M
83.14%
+128.30K
2025Q3
417
39.73M
84.87%
+2.04M
2025Q2
439
37.58M
87.40%
+1.14M
2025Q1
454
36.44M
84.55%
-9.64M
2024Q4
461
35.04M
82.31%
+2.84M
2024Q3
467
32.21M
81.37%
+1.29M
2024Q2
485
30.86M
99.60%
-5.54M
2024Q1
494
36.44M
103.37%
-17.72M
2023Q4
512
41.89M
103.68%
-1.06M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.92M
7.6%
+17.75K
+0.45%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.25M
4.36%
+112.27K
+5.25%
Dec 31, 2025
State Street Investment Management (US)
2.70M
5.22%
+250.62K
+10.25%
Dec 31, 2025
American Century Investment Management, Inc.
2.44M
4.72%
+57.06K
+2.40%
Dec 31, 2025
Charles Schwab Investment Management, Inc.
1.62M
3.13%
+237.15K
+17.16%
Dec 31, 2025
Palisade Capital Management, LLC
1.27M
2.45%
-160.25K
-11.24%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.25M
2.42%
-28.68K
-2.24%
Dec 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.16%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AdvisorShares Insider Advantage ETF
0.97%
Royce Quant Small-Cap Quality Value ETF
0.41%
State Street SPDR S&P Biotech ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.23%
Harbor Human Capital Factor US Small Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Pacer US Small Cap Cash Cows ETF
0.16%
Invesco RAFI US 1500 Small-Mid ETF
0.15%
Avantis US Small Cap Value ETF
0.14%
iShares Micro-Cap ETF
0.13%
View more
AdvisorShares Insider Advantage ETF
Proportion0.97%
Royce Quant Small-Cap Quality Value ETF
Proportion0.41%
State Street SPDR S&P Biotech ETF
Proportion0.28%
Federated Hermes MDT Small Cap Core ETF
Proportion0.23%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.19%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.18%
Pacer US Small Cap Cash Cows ETF
Proportion0.16%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.15%
Avantis US Small Cap Value ETF
Proportion0.14%
iShares Micro-Cap ETF
Proportion0.13%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
